Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Venlafaxine hydrochloride
Drug ID BADD_D02347
Description Venlafaxine (Effexor) is an antidepressant within the serotonin-norepinephrine reuptake inhibitor (SNRI) class of medications. It exerts its effects primarily by blocking the transporters involved in the reuptake of the neurotransmitters serotonin and norepinephrine, therefore leaving more active neurotransmitter in the synapse. Venlafaxine is officially approved for use in the management of major depressive disorder (MDD), generalized anxiety disorder (GAD), social anxiety disorder, and panic disorder. As of 2014, Canadian clinical practice guidelines recommend venlafaxine as a first-line option for treatment of generalized anxiety, social anxiety, panic disorder, major depressive disorder (MDD), and consider it a second-line option for management of obsessive-compulsive disorder (OCD) [A177226,A177235]. Venlafaxine is also used off-label for prophylaxis of migraine headaches [A177229], for reduction of vasomotor symptoms associated with menopause [A177238], and for management of neuropathic pain (although there is only minimal evidence of efficacy for this condition) [A177232].
Indications and Usage Venlafaxine is indicated in the management of major depressive disorder (MDD), generalized anxiety disorder (GAD), social anxiety disorder (social phobia), and panic disorder with or without agoraphobia. Venlafaxine is also used off-label for prophylaxis of migraine headaches [A177229], for reduction of vasomotor symptoms associated with menopause [A177238], and for management of neuropathic pain (although there is only minimal evidence of efficacy for this condition) [A177232]. It is also considered a second-line option for management of obsessive-compulsive disorder (OCD) [A177226, A177235].
Marketing Status approved
ATC Code N06AX16
DrugBank ID DB00285
KEGG ID D00821
MeSH ID D000069470
PubChem ID 62923
TTD Drug ID D0P1UX
NDC Product Code 75834-217; 82009-057; 57451-1207; 13811-713; 0093-7384; 0093-9149; 29033-045; 42291-899; 50268-817; 57237-176; 63187-420; 63629-2100; 68071-2427; 68382-035; 68788-7891; 68788-8072; 71205-369; 71335-9605; 71785-1007; 72888-181; 80425-0296; 0093-7386; 42291-897; 47335-760; 50090-5929; 50090-6301; 63629-9284; 65841-675; 68788-6806; 70518-0558; 70518-2532; 70518-2587; 70518-2659; 70518-3219; 71335-1213; 71335-1642; 42816-0833; 42816-0836; 55111-098; 13811-712; 16714-044; 16714-045; 16714-903; 0093-9148; 0093-9157; 33342-196; 43353-268; 50090-4853; 50268-819; 51655-323; 55111-453; 55700-914; 65862-407; 68084-698; 68788-7919; 0527-2605; 70518-3563; 70710-1700; 71610-013; 0615-7622; 55111-455; 55111-548; 55700-975; 57237-173; 58118-0335; 60760-187; 65841-671; 65841-674; 65841-753; 67046-557; 68382-036; 70518-1907; 70518-2121; 70518-2259; 70518-3136; 71335-1104; 72888-180; 0904-7077; 17511-131; 42816-0837; 65862-697; 72761-018; 13811-714; 16714-038; 0093-7385; 42291-898; 42806-601; 42806-602; 43353-234; 55154-3371; 61919-222; 65841-751; 65841-752; 65862-404; 65862-405; 65862-527; 68025-082; 68382-034; 68788-6834; 70518-2107; 70710-1698; 71921-172; 71921-173; 52286-0006; 16714-904; 33342-195; 47335-794; 50090-6215; 50268-818; 50771-002; 51655-223; 53002-1361; 53002-2361; 55111-454; 55111-546; 55700-816; 60760-121; 68084-709; 68788-8140; 70518-1385; 70518-2933; 71205-812; 71335-1812; 71335-9705; 0615-7621; 75834-219; 80425-0290; 0904-6469; 53104-7529; 65862-528; 16714-043; 33342-194; 0008-0837; 43353-233; 45865-647; 50090-5890; 50771-003; 50771-005; 55111-545; 55111-547; 57237-172; 57237-175; 60760-304; 63187-177; 68025-081; 68071-2393; 68071-2588; 68084-713; 0527-2604; 70518-0478; 70518-1976; 70710-1699; 71205-408; 71335-1338; 71785-1008; 72888-179; 12666-0004; 0904-7075; 65691-0126; 68069-0002; 13668-018; 0093-9147; 42806-603; 50771-001; 53002-1365; 55700-813; 60429-866; 60429-867; 65841-673; 68025-079; 70771-1837; 71335-1993; 71610-018; 71785-1006; 71921-174; 0615-8346; 75834-218; 80425-0297; 82009-056; 0904-6468; 0904-6470; 58598-0012; 65691-0036; 13668-019; 13668-020; 13811-715; 16714-905; 31722-004; 42708-054; 50090-6214; 51655-849; 53002-1366; 53002-2365; 57237-174; 62135-531; 68788-8068; 70518-3427; 70771-1836; 70771-1838; 71335-1864; 82009-058; 62331-044; 65344-0017; 29033-046; 31722-003; 0008-0836; 43353-798; 45865-643; 47335-759; 50090-5891; 50771-004; 53002-2366; 55111-549; 63187-481; 65841-672; 65862-406; 65862-408; 68025-080; 68071-2703; 68788-6424; 70518-2652; 71335-1868; 0904-7076; 66651-908; 0093-9163; 31722-002; 0008-0833; 47335-758; 50090-2180; 50090-5942; 55700-887
UNII 7D7RX5A8MO
Synonyms Venlafaxine Hydrochloride | Hydrochloride, Venlafaxine | Cyclohexanol, 1-(2-(dimethylamino)-1-(4-methoxyphenyl)ethyl)-, hydrochloride | 1-(2-(dimethylamino)-1-(4-methoxyphenyl)ethyl)cyclohexanol HCl | Wy 45030 | Wy-45030 | Wy45030 | Wy-45,030 | Wy 45,030 | Wy45,030 | Sila-Venlafaxine | Sila Venlafaxine | Effexor | Trevilor | Vandral | Efexor | Venlafaxine | Dobupal
Chemical Information
Molecular Formula C17H28ClNO2
CAS Registry Number 99300-78-4
SMILES CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O.Cl
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Abdominal pain07.01.05.002--
Abnormal dreams17.15.02.001; 19.02.03.001---
Accommodation disorder06.02.04.001---
Agitation17.02.05.012; 19.06.02.001--
Agranulocytosis01.02.03.001---
Akathisia17.01.02.002; 19.06.02.006--
Alopecia23.02.02.001--
Anaphylactic reaction10.01.07.001; 24.06.03.006--
Angioedema10.01.05.009; 22.04.02.008; 23.04.01.001---
Angle closure glaucoma06.03.01.001---
Anorgasmia19.08.01.001--
Apathy19.04.04.002---
Aplastic anaemia01.03.03.002---
Asthenia08.01.01.001---
Bleeding time prolonged13.01.02.002---
Blood cholesterol increased13.12.01.002--
Blood pressure increased13.14.03.005---
Blood prolactin increased13.10.03.002---
Bruxism07.01.06.008; 19.11.03.001---
Chills08.01.09.001; 15.05.03.016--
Confusional state17.02.03.005; 19.13.01.001--
Constipation07.02.02.001--
Coordination abnormal17.02.02.004---
Delirium19.13.02.001--
Diarrhoea07.02.01.001--
Dizziness02.11.04.006; 17.02.05.003; 24.06.02.007--
Dry mouth07.06.01.002--
Dysgeusia07.14.03.001; 17.02.07.003--
Dyskinesia17.01.02.006--
Dyspepsia07.01.02.001--
The 1th Page    1 2 3 4    Next   Last    Total 4 Pages